Associate Prof. @TelAvivUni Stat & OR Department. (Bio)statistics, causal inference, etc.

Joined April 2015
74 Photos and videos
Daniel Nevo retweeted
๐ŸšจNew in AER๐Ÿšจ: "Negative Control Falsification Tests for IV Designs" (@DanieliOren, @DanielNevo, Itai Walk, Bar Weinstein, @danzeltzer). doi.org/10.1257/aer.20240636 Common placebo test implementations may reject valid IVs. We're coming to save your IVs! ๐Ÿงต
1
51
173
15,917
ืจื’ืข ืฉื™ื ืคื•ื˜ื ืฆื™ืืœื™ ื‘ืงืจื™ื™ืจื”, ื”ื˜ื™ื™ืง ืฉืœื™ ืžื”ืจ ืœืคื ื™ ืฉืื ื™ ืขืฃ ื”ื•ื ืฉื”ืืกื˜ืจื˜ื’ื™ื” ื›ืฉื”ืžื˜ืจื” ืœืžืงืกื ืกื™ื›ื•ื™ ืœื–ื›ื•ืช ื”ื™ื ืœื ืœืคื–ืจ ืกื™ื›ื•ื ื™ื .
Replying to @Oriorori
ืขื ืกื’ืœ ืคื ื˜ื–ื™ ืžืœื ื”ืจื•ื‘ ื‘ื—ืจื• ื‘ืจืืžืก ื›ืืœื•ืคื”, ื•ืจืง 2 ื‘ืกื™ืื˜ืœ, 1 ื“ื ื‘ืจ ื•-1 ืคืื˜ืก. ืื‘ืœ ืื ืžืกืชื›ืœื™ื ืขืœ ืžื—ื•ืฅ ืœื˜ื•ืค 30 ืžื™ื“ ืžื•ืฆืื™ื ืขื ืคื•ื˜ื ืฆื™ืืœ ืงืคื™ืฆื” ืงื“ื™ืžื” ื’ื‘ื•ื” ืžืื•ื“, 3 ืžืฉืชืชืคื™ื ืขื ืกื’ืœ ืคื ื˜ื–ื™ ืžืœื ืฉื™ืชืŸ ืœื”ื ื™ืชืจื•ืŸ: @DanielNevo @samisaviv @crookedteeth287 - ื•ืžื” ืฉื ื”ื“ืจ ื›ืœ ืื—ื“ ืžื”ื ื”ื™ืžืจ ืขืœ ืกื•ืคืจื‘ื•ืœ ืฉื•ื ื” โฌ‡๏ธ
3
134
New version of our paper!
25 Feb 2025
Hey ๐Ÿ‘‹ #econtwitter new version of the RD-DID paper - arxiv.org/abs/2408.05847 Some of whats new: - Iden. and est. of composition effects - Different SE under cross section / panel w. constant or time-varying running variables - A package (my first!) Cheers!
4
304
Daniel Nevo retweeted
Our new paper, led by Yaki Saciuk, is out in @NatureComms! nature.com/articles/s41467-0โ€ฆ We leverage allergy to penicillin as an instrumental variable, and verify it with negative control outcomes, to get causal estimates of antibiotic use on future resistance.
3
10
559
Daniel Nevo retweeted
ื™ืขืจื™ ื•ื™ื’ื“ืจ ื”ื•ื ื“ื•ืงื˜ื•ืจื ื˜ ื‘ืงื‘ื•ืฆื” ืฉืœื™ ื‘ืื•ื ื™ื‘ืจืกื™ื˜ืช ืช"ื (ื•ืžื™ืœื•ืื™ืžื ื™ืง ืœื•ื—ื) ืฉืื™ื‘ื“ ื‘ืฉื‘ื•ืข ืฉืขื‘ืจ ืืช ืืฉืชื• ืขื ื‘ืจ ื‘ืคื™ื’ื•ืข ื”ืจืฆื—ื ื™ ื‘ื™ืคื•. ืœื™ืขืจื™ ืฆืคื•ื™ื” ื”ืชืžื•ื“ื“ื•ืช ืงืฉื” ืขื ื”ืฉื›ื•ืœ ื•ื”ื—ื™ื™ื ื‘ืชื•ืจ ืื‘ ื—ื“-ื”ื•ืจื™, ื‘ื™ืŸ ื”ื™ืชืจ ืžื”ืคืŸ ื”ื›ืœื›ืœื™. ืืชื ืžื•ื–ืžื ื™ื ืœืชืจื•ื ื•ืœืฉืชืฃ ืืช ื”ืคื•ืกื˜. ื›ืœ ืชืจื•ืžื” ืชืขื–ื•ืจ! giveback.co.il/project/80886
6
81
289
16,324
Come work with us!
2
6
1,948
Check out our new working paper on correcting invalid regression discontinuity designs. Led by talented Econ PhD student Dor Leventer (@DorLev3) ! ๐Ÿ“œarxiv.org/abs/2408.05847

13 Aug 2024
๐Ÿ“ข@DanielNevo and I have a new WP out๐Ÿ“ข In the paper, we present a general framework for identification in RD designs when continuity is violated using multiple time period data, which we term RD-DID A thread 1/n arxiv.org/abs/2408.05847 #EconTwitter #Econometrics
1
13
397
Congratulations to TAD members: Prof. Yoav Benjamini, Prof. Daniel Yekutieli, and Prof. Ruth Heller for winning the prestigious 2024 Rousseeuw Prize for Statistics, for their pioneering work on the False Discovery Rate (FDR). Read more> did.li/NIYlC
2
9
697
Daniel Nevo retweeted
Falsification tests are often too harsh and people can find problems even when their IV is exogenous. Come hear more in my #NBERSI labor studies talk tomorrow (Thursday) at 10:30 am.
WP๐Ÿšจ with @danzeltzer @DanielNevo @B_WNSN & Walk. If you used an IV, you likely ran a falsification or placebo test for exogeneity. We show these tests can be *too harsh*. They can flag issues even if the IV is exogenous.#EconTwitter #CausalInference arxiv.org/abs/2312.15624 ๐Ÿงต>>
1
7
24
2,386
Daniel Nevo retweeted
5 Jun 2024
New CEPR Discussion Paper - DP19127 Negative Control Falsification Tests for Instrumental Variable Designs @DanieliOren, @DanielNevo, Itai Walk, @B_WNSN & @danzeltzer @TelAvivUni ow.ly/VQPH50S8fg0 #CEPR_EH #CEPR_IO #CEPR_LE #CEPR_PE #econometrics
4
9
2,098
Daniel Nevo retweeted
I have several exciting openings for PhD students and postdocs in the context of my advanced ERC grant #ERCAdG on Assumption-lean (Causal) Modeling and Estimation. Please spread the news! users.ugent.be/~svsteela/ @DassGhent @UGent_fwe @ResearchUGent @UGent @ERC_Research

23
37
5,298
Daniel Nevo retweeted
#ืœื™ื™ื‘ื˜ื•ื•ื™ื˜ืจ ื‘ื•ืงืจ ื˜ื•ื‘, ื”ื™ื•ื ื›ื ืก ื”ืื™ื’ื•ื“ ื”ื™ืฉืจืืœื™ ืœืกื˜ื˜ื™ืกื˜ื™ืงื” ื‘ืกืคืจื™ื” ื”ืœืื•ืžื™ืช. ืžืชื—ื™ืœื™ื ืขื ืžื•ืฉื‘ ื ืชื•ื ื™ื ื”ื—ื™ืจื•ื - ืคืจื•ืค' ืงืจื™ืŸ ื ื”ื•ืŸ ืžืกืคืจืช ืขืœ ื”ืงืžืช ืžืจื›ื– ื”ื ืขื“ืจื™ื. ื‘ื™ืงืฉื• ืจืฉื™ืžื•ืช ืชื•ืฉื‘ื™ื ื‘ื“ืจื•ื ืื‘ืœ ืœืžืฉืจื“ื™ื ื”ืžืžืฉืœืชื™ื™ื ืœื ื”ื™ื” ืคืจื•ื˜ื•ืงื•ืœ ืœืฉืชืฃ ืžื™ื“ืข ืขื ื’ื•ืคื™ื ืื–ืจื—ื™ื™ื. ืื– ื‘ืžืงื•ื ืืกืคื• ืžื™ื“ืข ืžืฆื•ืœื ืžื”ืฉื˜ื—
2
1
19
855
#CausalTwitter, check out our new paper๐Ÿ“œ! We provide theoretical justification for and tons of practical guidance on using negative controls for falsification tests for IV exogeneity. I had the privilege of presenting this paper at the last @TheEuroCIM.
WP๐Ÿšจ with @danzeltzer @DanielNevo @B_WNSN & Walk. If you used an IV, you likely ran a falsification or placebo test for exogeneity. We show these tests can be *too harsh*. They can flag issues even if the IV is exogenous.#EconTwitter #CausalInference arxiv.org/abs/2312.15624 ๐Ÿงต>>
5
16
1,351
Daniel Nevo retweeted
WP๐Ÿšจ with @danzeltzer @DanielNevo @B_WNSN & Walk. If you used an IV, you likely ran a falsification or placebo test for exogeneity. We show these tests can be *too harsh*. They can flag issues even if the IV is exogenous.#EconTwitter #CausalInference arxiv.org/abs/2312.15624 ๐Ÿงต>>
1
25
96
28,981
Daniel Nevo retweeted
๐Ÿ—“๏ธFri 10am at SOLE: @DanieliOren presents our work on falsification tests for IV designs!
2
13
2,558
ื ื™ืฉืชื™: "SUTVA assumption"
ืื•ืงื™ื™ ืžืจื’ื™ืฉ ืœื™ ืฉื”ื˜ื•ื•ื™ื˜ืจ ืžืœื ื‘ืกื—ืœื” ื•ื”ื•ื ื–ืงื•ืง ืœื”ืคืขืœื” ืื—ืช ื‘ืฉื‘ื™ืœ ื”ืคืืŸ- ื˜ืขื•ื™ื•ืช ืฉืœ ืื ืฉื™ื ื‘ื”ื‘ื ืช ื”ืงื•ื ืกืคื˜ ืฉืœ ืจืืฉื™ืช ืชื™ื‘ื•ืช. ืื ื™ ืืชื—ื™ืœ- ื”ื’ืจื™ ืื™ืคืฉื”ื• ืฉื ื‘ืชื—ื™ืœืช ื”ืžืœื—ืžื”: "ืกื“"ื› ื”ื›ื•ื—ื•ืช"
1
6
372
Me: ChatGPT, can you have a look at slide number five in my slides and let me know if there are any typos or grammar issues? ChatGPT:
4
258
In a recent phase 2 Dengue vaccine trial, side effects varied between vaccine and placebo arms. We call for phase 3 trials to measure participantsโ€™ beliefs about receiving the active vaccine or placebo. See our Correspondence in @TheLancetInfDis thelancet.com/journals/laninโ€ฆ
1
1
167
For more details, check out our paper, correspondence and R code: ๐Ÿ“„ journals.lww.com/epidem/fullโ€ฆ ๐Ÿ–ฅ๏ธgithub.com/daniel258/Distingโ€ฆ ๐Ÿ—ž๏ธthelancet.com/journals/laninโ€ฆ #VaccineEfficacy #EpiTwitter #CausalInference

1
161